IDEXX Laboratories Inc
IDXX
676.21
-13.44
-1.95%
IDEXX Laboratories Inc
US · IDXX
#543 by market cap
Listed 1970
676.21
-13.44
-1.95%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$17.68 Million in Common StockMarket Newswire · 2026/11/6
-
Company notice
IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer Underberg Sharon E.SEC · 2026/11/6
-
Company notice
IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer FENNELL GEORGESEC · 2026/11/13
-
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $700 to $810Market Newswire · 2026/11/4
-
Rating change
KeyBanc Initiates IDEXX Laboratories Inc(IDXX.US) With Hold RatingMarket Newswire · 2026/10/12
-
Form 144 | IDEXX Laboratories Inc(IDXX.US) Officer Proposes to Sell 6.13 Million in Common StocksMarket Newswire · 2026/11/5
-
Rating change
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $670Market Newswire · 2026/9/16
-
Company notice
IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer MAZELSKY JONATHAN JAYSEC · 2026/11/19
-
Rating change
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $700Market Newswire · 2026/11/3
-
Company notice
IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Director JUNIUS DANIEL MSEC · 2026/11/6
-
Rating change
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy RatingMarket Newswire · 2026/10/2
-
Rating change
Analysts Conflicted on These NA Names: Rapport Therapeutics, Inc. (RAPP), Idexx Laboratories (IDXX) and Waystar Holding Corp. (WAY)TipRanks · 2026/9/16
-
Rating change
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $675Market Newswire · 2026/8/14
-
Rating change
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665Market Newswire · 2026/8/14
-
Rating change
J.P. Morgan Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $750Market Newswire · 2026/10/16
-
Rating change
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $805Market Newswire · 2026/11/3
-
Company notice
IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer Lane MichaelSEC · 2026/11/21
-
Rating change
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $627Market Newswire · 2026/10/27
-
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$6.13 Million in Common StockMarket Newswire · 2026/11/6
-
Form 144 | IDEXX Laboratories Inc(IDXX.US) Officer Proposes to Sell 17.68 Million in Common StocksMarket Newswire · 2026/11/5
-
Company notice
IDEXX Laboratories Inc | 144/A: OthersSEC · 2026/11/6
-
Company notice
IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer MAZELSKY JONATHAN JAYSEC · 2026/11/6
-
Company notice
IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer Lane MichaelSEC · 2026/11/6
-
Rating change
Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670Market Newswire · 2026/8/5
-
Rating change
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $660Market Newswire · 2026/7/8
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.
IDEXX Laboratories Inc discussion 0 comments